163 related articles for article (PubMed ID: 34976820)
1. MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment.
Zhang W; Liu Z; Yang Z; Feng C; Zhou X; Tu C; Li Z
Front Oncol; 2021; 11():781386. PubMed ID: 34976820
[TBL] [Abstract][Full Text] [Related]
2. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
Yang L; Hu X; Xu L
Tumour Biol; 2012 Oct; 33(5):1445-54. PubMed ID: 22528943
[TBL] [Abstract][Full Text] [Related]
3. Association Between
Meng H; Huang S; Yang Y; He X; Fei L; Xing Y
Front Genet; 2021; 12():698590. PubMed ID: 34899823
[TBL] [Abstract][Full Text] [Related]
4. MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients.
Xu L; Wang L; Xue B; Wang S
J Bone Oncol; 2018 Nov; 13():143-147. PubMed ID: 30591868
[TBL] [Abstract][Full Text] [Related]
5. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis expounding the relationship between methylene tetrahydrofolate reductase gene polymorphism and the risk of intracerebral hemorrhage among populations.
Zou XL; Yao TX; Deng L; Chen L; Li Y; Zhang L
Front Genet; 2022; 13():829672. PubMed ID: 35991566
[No Abstract] [Full Text] [Related]
7. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.
Yan Y; Han F; Fu H; Xia W; Qin X
Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831
[TBL] [Abstract][Full Text] [Related]
8. MTHFR polymorphisms (rs1801133) and systemic lupus erythematosus risk: A meta-analysis.
Zhou HY; Yuan M
Medicine (Baltimore); 2020 Oct; 99(40):e22614. PubMed ID: 33019481
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
10. Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis.
Zhu C; Liu YW; Wang SZ; Li XL; Nie XL; Yu XT; Zhao LB; Wang XL
Pharmacogenomics J; 2018 May; 18(3):450-459. PubMed ID: 28696419
[TBL] [Abstract][Full Text] [Related]
11. Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: A meta-analysis.
Zhang HZ; Wu JH; Huang Q; Yang Q; Sima Q; Chen KY; Li ZR; He GH
J Cosmet Dermatol; 2021 Jul; 20(7):2359-2368. PubMed ID: 33219596
[TBL] [Abstract][Full Text] [Related]
12. Associations of C677T polymorphism in methylenetetrahydrofolate reductase (MTHFR) gene with male infertility risk: A meta-analysis.
Hong HH; Hu Y; Yu XQ; Zhou L; Lv MQ; Sun Y; Ren WJ; Zhou DX
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():101-109. PubMed ID: 28363185
[TBL] [Abstract][Full Text] [Related]
13. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
14. Cumulative review and meta-analyses on the association between MTHFR rs1801133 polymorphism and breast cancer risk: a pooled analysis of 83 studies with 74,019 participants.
Zhang Y; Jia H; Wang S; Jiang D
Minerva Med; 2017 Feb; 108(1):57-73. PubMed ID: 27824246
[TBL] [Abstract][Full Text] [Related]
15. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
17. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression.
Rai V
Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):60-67. PubMed ID: 28968218
[TBL] [Abstract][Full Text] [Related]
18. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
19. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
[TBL] [Abstract][Full Text] [Related]
20. Association of methylenetetrahydrofolate reductase (MTHFR) rs1801133 (677C>T) gene polymorphism with ischemic stroke risk in different populations: An updated meta-analysis.
Zhao L; Li T; Dang M; Li Y; Fan H; Hao Q; Song D; Lu J; Lu Z; Jian Y; Wang H; Wang X; Wu Y; Zhang G
Front Genet; 2022; 13():1021423. PubMed ID: 36685916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
